The groundbreaking therapy of this peptide represents a major development in the management of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide883269.blogacep.com/47675786/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment